EDAP TMS reported EUR-6.47M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
AngioDynamics USD 5.94M 3.78M Sep/2025
Boston Scientific USD 1.63B 27M Jun/2026
EDAP TMS EUR -6.47M 1.54M Mar/2026
Henry Schein USD 288M 1000K Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Veracyte USD 43.96M 1.16M Jun/2026